Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: A meta-analysis of randomized trials

European Heart Journal

Volumn 29, Issue 21, 2008, Pages 2592-2600

  Whitlock, Richard P ^a   Chan, Simon ^a   Devereaux, P J ^a   Sun, Jack ^a   Rubens, Fraser D ^b   Thorlund, Kristian ^c   Teoh, Kevin H T ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c Mental Health Services CPH   (Denmark)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Clinical outcomes; Inflammatory response; Meta analysis; Steroids

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; MORTALITY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TRANSFUSION; WOUND COMPLICATION;

ADULT; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; COAGULANTS; EPIDEMIOLOGIC METHODS; HUMANS; PERIOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEROIDS;

EID: 55749083074     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn333     Document Type: Review

References (54)

1. Chaney MA. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. Chest 2002;121:921-931.
2. Teoh KH, Bradley CA, Gauldie J, Burrows H. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 1995;92:II347-II353.
3. Vincent JL, Wan S, Yim AP. Steroids in cardiopulmonary bypass. Crit Care Med 2000;28:3373-3374.
4. Kirklin JK, McGriffin DC. Early complications following cardiac surgery. Cardiovasc Clin 1987;17:321-342.
5. Whitlock RP, Rubens FD, Young E, Teoh KH. Pro: steroids should be used for cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2005;19:250-254.
6. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
8. Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials 1997;18:580-593; discussion 661-666.
9. Verrier ED, Shernan SK, Taylor KM, Van de Werf F, Newmann MF, Chen JC, Carrier M, Haverich A, Malloy KJ, Adams PX, Todaro TG, Mojcik CF, Rollins SA, Levy JH. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 2004;291:2319-2327.
10. Tardif JC, Carrier M, Kandzari DE, Emery R, Cote R, Heinonen T, Zettler M, Hasselblad V, Guertin MC, Harrington RA. Effects of pyridoxal-50-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. J Thorac Cardiovasc Surg 2007;133:1604-1611.
11. Whitlock RP, Young E, Noora J, Farrokhyar F, Blackall M, Teoh KH. Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS; SIRS I. J Surg Res 2006;132:188-194.
12. Abd El-Hakeem EE, El-Minshawy AMA. Influence of dexamethasone on cytokine balance in patients undergoing valve replacement surgery. Egypt J Anest 2003;19:205-214.
13. Andersen LW, Baek L, Thomsen BS, Rasmussen JP. Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery. J Cardiothorac Anesth 1989;3:544-549.
14. Bourbon A, Vionnet M, Leprince P, Vaissier E, Copeland J, McDonagh P, Debre P, Gandjbakhch I. The effect of Methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response. Eur J Cardiothorac Surg 2004;26:932-938.
15. Celik JB, Gormus N, Okesli S, Gormus ZI, Solak H. Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass; effects on TNF-alpha, IL-6, IL-8, IL-10. Perfusion 2004;19:185-191.
16. Chaney MA, Nikolov MP, Blakeman B, Bakhos M, Slogoff S. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg 1998;87:27-33.
17. Chaney MA, Durazo-Arvizu RA, Nikolov MP, Blakeman BP, Bakhos M. Methylprednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation. J Thorac Cardiovasc Surg 2001;121:561-569.
18. Coetzer M, Coetzee A, Rossouw G. The effect of methylprednisolone given prior to cardiopulmonary bypass on indices of gas exchange. Cardiovasc J S Afr 1996;86:C188-C192.
19. Codd JE, Wiens RD, Barner HB, Kaiser GC, Willman VL. Steroids and myocardial preservation. J Thor Cardiovasc Surg 1977;74:418-422.
20. Enc Y, Karaca P, Ayoglu U, Camur G, Kurc E, Cicek S. The acute cardioprotective effect of glusocorticoid in myocardial ischemia-reperfusion injury occurring during cardiopulmonary bypass. Heart Vessels 2006;21:152-156.
21. El Azab SR, Rosseel PM, de Lange JJ, Groenevel ABJ, van Strik R, van Wijk EM, Scheffer GJ. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br J Anaesth 2002;88:496-501.
22. Fecht DC, Magovern GJ, Park SB, Merkow LP, Dixon CM, Dosios T, Pardo M. Beneficial effects of methylprednisolone in patients on cardiopulmonary bypass. Circ Shock 1978;5:415-422.
23. Ferries LH, Marx JJ Jr, Ray JF III. The effect of methylprednisolone on complement activation during cardiopulmonary bypass. J Extra-Corporeal Technol 1984;16: 83-88.
24. Fillinger MP, Rassias AJ, Guyre PM, Sanders JH, Beach M, Pahl J, Watson RB, Whalen PK, Yeo KTJ, Yeager MP. Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery. J Cardiothorac Vasc Anesth 2002;16:163-169.
25. Giomarelli P, Scolleta S, Borrelli E, Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin 10. Ann Thorac Surg 2003;76:117-123.
26. Halvorsen P, Raeder J, White PF, Almdahl SM, Nordstand K, Saatvedt K, Veel T. The effects of dexamethasone on side effects after coronary revascularization procedures. Anesth Analg 2003;96:1578-1583.
27. Halonen J, Halonen P, Jarvinen O, Taskinen P, Auvinen T, Tarkka M, Hippelainen M, Juvonen T, Hartikainen J, Hakala T. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery. JAMA 2007;297:1562-1567.
28. Harig F, Feyrer R, Mahmoud FO, Blum U, von der Emde J. Reducing the postpump syndrome by using heparin-coated circuits, steroid, or aprotonin. Thorac Cardiovasc Surg 1999;47:111-118.
29. Jansen NJ, van Oeveren W, van den BL, Oudemans-van Straaten HM, Stoutenbeek CP, Joen MC, Roosendaal KJ, Eysman L, Wildevuur CR. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;102:515-525.
30. Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D, Nagy A, Schuetz A, Lamm P, Knoll A, Peter K. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003;31:1068-1074.
31. Loef BG, Henning RH, Epema AH, Rietman GW, van Oeveren W, Navis GJ, Ebels T. Effect of dexamethasone on peri-operative renal function impairment during cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2004;93:793-798.
32. Liakopolous OJ, Schmitto JD, Kazmaier S, Brauer A, Quintel M, Schoendube FA, Dorge H. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann Thorac Surg 2007;84:110- 119.
33. Mayumi H, Zhang QW, Nakashima A, Masuda M, Kohno H, Kawachi Y, Tasui H. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass. Ann Thorac Surg 1997;63:129-137.
34. McBride WT, Allen S, Gormley SM, Young IS, McClean E, MacGowan SW, Elliott P, McMurray TJ, Armstrong MA. Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery. Cytokine 2004;27:81-89.
35. Morton JR, Hiebert CA, Lutes CA, White RL. Effect of methylprednisolone on myocardial preservation during coronary artery surgery. Am J Surg 1976;131: 419-422.
36. Niazi Z, Flodin P, Joyce L, Smith J, Mauer H, Lillehei RC. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery. Chest 1979;76:262-268.
37. Oliver WC Jr, Nuttall GA, Orsulak TA, Bamlet WR, Abel MD, Ereth MH, Schaff HV. Hemofiltration but not steroids results in earlier tracheal extubation following cardiopulmonary bypass: a prospective, randomized double-blind trial. Anesthesiology 2004;101:327-339.
38. Prasongsukarn K, Abel JG, Jamieson WRE, Cheung A, Russell JA, Walley KR, Lichtenstein SV. The effects of steroids on the occurrence of post-operative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg 2005;130:93-98.
39. Rao G, King J, Ford W, King G. The effects of methylprednisolone on the complications of coronary artery surgery. Vasc Surg 1977;11:1-7.
40. Rubens FD, Nathan H, Labow R, Williams KS, Wozny D, Karsh J, Ruel M, Mesana T. Effects of Methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass. Ann Thorac Surg 2005;79:655-665.
41. Rumalla V, Calvano SE, Spotnitz AJ, Krause TJ, Lin E, Lowry SF. The effects of glucocorticoid therapy on inflammatory responses to coronary artery bypass graft surgery. Arch Surg 2001;136:1039-1044.
42. Sano T, Morita S, Masuda M, Yasui H. Minor infection encouraged by steroid administration during cardiac surgery. Asian Cardiovasc Thorac Ann 2006;14:505-510.
43. Schurr UP, Zund G, Hoerstrup SP, Grunerfelder J, Maly FE, Vogt PR, Turina MI. Preoperative administration of steroids: influence on adhesion molecules and cytokines after cardiopulmonary bypass. Ann Thorac Surg 2001;72:1316-1320.
44. Tassani P, Richter JA, Barankay A, Braun SL, Haehnel C, Spaeth P, Schad H, Meisner H. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures? J Cardiothorac Vasc Anesth 1999;13:165-172.
45. Toft P, Christiansen K, Tonnesen E, Nielsen CH, Lillevang S. Effect of methylprednisolone on the oxidative burst activity, adhesion molecules and clinical outcome following open heart surgery. Scand Cardiovasc J 1997;31:283-288.
46. Turkoz A, Cigli A, But K, Sezgin N, Turkoz R, Gulcan O, Ersoy MO. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery. J Cardiothorac Vasc Anesth 2001;15:603-610.
47. Vallejo Jl, Gimenez-Fernandez R, Mainer JL, Rivera R. Clinical analysis of the protective effect of methylprednisolone on the heart. Rev Esp Cardiol 1977;30:705-709.
48. Volk T, Schmutzler M, Engelhardt L, Docke WD, Volk HD, Konertz W, Kox WJ. Influence of aminosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass. Crit Care Med 2002;29:2137-2142.
49. Volk T, Schmutzler M, Engelhardt L, Pantke U, Stangl K, Grune T, Wernecke KD, Konertz W, Kox WJ. Effects of different steroid treatment on reperfusion-associated production of reactive oxygen species and arrythmias during coronary surgery. Acta Anaesthesiol Scand 2003;47:667-674.
50. Wan S, LeClerc JL, Huynh CH, Schmartz D, DeSmet JM, Yim APC, Vincent JL. Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999;117:1004- 1008.
51. Weis F, Kilger E, Roozendaal B, de Quervain DJF, Lamm P, Schmidt M, Schmolz M, Briegel J, Schelling G. Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: a randomized study. J Thorac Cardiovasc Surg 2006;131:277-282.
52. Yared JP, Starr NJ, Torres FK, Bashour CA, Bourdakos G, Piedmonte M, Michener JA, Davis JA, Rosenberger TE. Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery. Ann Thorac Surg 2000;69:1420-1424.
53. Yared JP, Bakri MH, Erzurum SC, Moravec CS, Laskowski DM, Van Wagoner DR, Mascha E, Thornton J. Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo controlled trial. J Cardiothorac Vasc Anesth 2007;21:68-75.
54. Yilmaz M, Ener S, Akalin H, Sagdic K, Serdar OA, Cengiz M. Effect of low-dose methyl prednisolone on serum cytokine levels following extracorporeal circulation. Perfusion 1999;14:201-206.